You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.
Altmetrics
Downloads
149
Views
60
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Intra-operative analgesia strategies | TAPB + Morphine 5 mg + Paracetamol 1 gr + Ketorolac 30 mg/Ibuprofen 600 mg | |
ESPB + Paracetamol 1 gr + Ketorolac 30 mg/Ibuprofen 600 mg | ||
Post-operative analgesia strategy | POD 0-1 | Paracetamol 1 gr x 3/die Ketorolac 30 mg if NRS>4 (If NSAIDs forbidden, Morphine 3 mg s.c.) |
POD 2 until discharge | Paracetamol 1 gr if NRS>4 Ketorolac 30 mg if paracetamol not effective (If NSAIDs forbidden, Morphine 3 mg s.c.) |
TAPB-group (n. 93) | ESPB-group (n. 97) | p value | |
---|---|---|---|
Age, yr | 64 + 13 | 66 + 12 | 0.174 |
Sex, m/f n | 77/16 | 87/10 | 0.207 |
BMI, Kg/m2 | 26 + 4 | 25 + 4 | 0.646 |
ASA class I II III |
14 68 11 |
5 81 11 |
|
Type of surgery, n (%) Partial nephrectomy Radical nephrectomy Radical prostatectomy Adrenalectomy other |
17 (18) 13 (14) 57 (62) 2 (2) 4 (4) |
18 (19) 13 (13) 58 (60) 1 (1) 7 (7) |
|
VLS/robotic surgery, n | 53/41 | 61/36 | 0.104 |
Duration of surgery, min | 132 + 55 | 150 + 51 | 0.121 |
Duration of anaesthesia, min | 173 + 53 | 177 + 50 | 0.592 |
TAPB-group (n. 93) | ESPB-group (n. 97) | p value | |
---|---|---|---|
Total ropivacaine consumption, mg | 305 + 60 | 170 + 25 | <0.001 |
Total patients requiring a rescue dose, n | 43 | 33 | 0.104 |
Total rescue dose requested, n | 3 (2-5) | 1 (0-2) | <0.001 |
Total NSAIDs consumption as rescue in POD1, n | 40 | 26 | 0.092 |
Total morphine consumption as rescue in POD1, n | 2 | 0 | 0.502 |
Total Paracetamol consumption as rescue in POD2 and over, n | 12 | 5 | 0.005 |
Total NSAIDs consumption as rescue in POD2 and over, n | 29 | 6 | <0.001 |
Total morphine consumption as rescue in POD2 and over, n | 6 | 0 | 0.033 |
Time to first rescue analgesia, day | 1 (0-1) | 1 (0-1) | 0.195 |
Intraoperative complications, n -bradycardia -hypotension |
0 0 |
0 0 |
0.999 0.999 |
Postoperative complications, n -PONV -block related complications |
18 0 |
4 0 |
0.001 0.999 |
Length of stay, n | 4 (3-6) | 4 (3-5) | 0.401 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Submitted:
30 October 2023
Posted:
31 October 2023
You are already at the latest version
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
30 October 2023
Posted:
31 October 2023
You are already at the latest version
Intra-operative analgesia strategies | TAPB + Morphine 5 mg + Paracetamol 1 gr + Ketorolac 30 mg/Ibuprofen 600 mg | |
ESPB + Paracetamol 1 gr + Ketorolac 30 mg/Ibuprofen 600 mg | ||
Post-operative analgesia strategy | POD 0-1 | Paracetamol 1 gr x 3/die Ketorolac 30 mg if NRS>4 (If NSAIDs forbidden, Morphine 3 mg s.c.) |
POD 2 until discharge | Paracetamol 1 gr if NRS>4 Ketorolac 30 mg if paracetamol not effective (If NSAIDs forbidden, Morphine 3 mg s.c.) |
TAPB-group (n. 93) | ESPB-group (n. 97) | p value | |
---|---|---|---|
Age, yr | 64 + 13 | 66 + 12 | 0.174 |
Sex, m/f n | 77/16 | 87/10 | 0.207 |
BMI, Kg/m2 | 26 + 4 | 25 + 4 | 0.646 |
ASA class I II III |
14 68 11 |
5 81 11 |
|
Type of surgery, n (%) Partial nephrectomy Radical nephrectomy Radical prostatectomy Adrenalectomy other |
17 (18) 13 (14) 57 (62) 2 (2) 4 (4) |
18 (19) 13 (13) 58 (60) 1 (1) 7 (7) |
|
VLS/robotic surgery, n | 53/41 | 61/36 | 0.104 |
Duration of surgery, min | 132 + 55 | 150 + 51 | 0.121 |
Duration of anaesthesia, min | 173 + 53 | 177 + 50 | 0.592 |
TAPB-group (n. 93) | ESPB-group (n. 97) | p value | |
---|---|---|---|
Total ropivacaine consumption, mg | 305 + 60 | 170 + 25 | <0.001 |
Total patients requiring a rescue dose, n | 43 | 33 | 0.104 |
Total rescue dose requested, n | 3 (2-5) | 1 (0-2) | <0.001 |
Total NSAIDs consumption as rescue in POD1, n | 40 | 26 | 0.092 |
Total morphine consumption as rescue in POD1, n | 2 | 0 | 0.502 |
Total Paracetamol consumption as rescue in POD2 and over, n | 12 | 5 | 0.005 |
Total NSAIDs consumption as rescue in POD2 and over, n | 29 | 6 | <0.001 |
Total morphine consumption as rescue in POD2 and over, n | 6 | 0 | 0.033 |
Time to first rescue analgesia, day | 1 (0-1) | 1 (0-1) | 0.195 |
Intraoperative complications, n -bradycardia -hypotension |
0 0 |
0 0 |
0.999 0.999 |
Postoperative complications, n -PONV -block related complications |
18 0 |
4 0 |
0.001 0.999 |
Length of stay, n | 4 (3-6) | 4 (3-5) | 0.401 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Jung Choi
et al.
JPM,
2022
Cosmin Balan
et al.
Medicina,
2022
© 2024 MDPI (Basel, Switzerland) unless otherwise stated